MeSH Review:
Blast Crisis
- Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea. Koller, C.A., Miller, D.M. N. Engl. J. Med. (1986)
- The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. Ahuja, H., Bar-Eli, M., Arlin, Z., Advani, S., Allen, S.L., Goldman, J., Snyder, D., Foti, A., Cline, M. J. Clin. Invest. (1991)
- Glucocorticosteroids induce DNA fragmentation in human lymphoid leukemia cells. Distelhorst, C.W. Blood (1988)
- Adenosine deaminase and ecto-5'-nucleotidase activities in various leukemias with special reference to blast crisis: significance of ecto-5'-nucleotidase in lymphoid blast crisis of chronic myeloid leukemia. Koya, M., Kanoh, T., Sawada, H., Uchino, H., Ueda, K. Blood (1981)
- Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis. Valent, P., Spanblöchl, E., Bankl, H.C., Sperr, W.R., Marosi, C., Pirc-Danoewinata, H., Virgolini, I., Eichler, H.G., Agis, H., Sillaber, C. Blood (1994)
- Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. Druker, B.J., Sawyers, C.L., Kantarjian, H., Resta, D.J., Reese, S.F., Ford, J.M., Capdeville, R., Talpaz, M. N. Engl. J. Med. (2001)
- Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia. Takasaki, Y., Robinson, W.A., Tan, E.M. J. Natl. Cancer Inst. (1984)
- A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. Robinson, R.A., DeVita, V.T., Levy, H.B., Baron, S., Hubbard, S.P., Levine, A.S. J. Natl. Cancer Inst. (1976)
- Target cell in chronic myeloid leukaemia and its relationship to acute lymphoid leukaemia. Janossy, G., Roberts, M., Greaves, M.F. Lancet (1976)
- Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop. Roumiantsev, S., Shah, N.P., Gorre, M.E., Nicoll, J., Brasher, B.B., Sawyers, C.L., Van Etten, R.A. Proc. Natl. Acad. Sci. U.S.A. (2002)
- Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia. Nitta, M., Kato, Y., Strife, A., Wachter, M., Fried, J., Perez, A., Jhanwar, S., Duigou-Osterndorf, R., Chaganti, R.S., Clarkson, B. Blood (1985)
- Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity. Tricot, G.J., Jayaram, H.N., Lapis, E., Natsumeda, Y., Nichols, C.R., Kneebone, P., Heerema, N., Weber, G., Hoffman, R. Cancer Res. (1989)
- High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis. Iacoboni, S.J., Plunkett, W., Kantarjian, H.M., Estey, E., Keating, M.J., McCredie, K.B., Freireich, E.J. J. Clin. Oncol. (1986)
- In vitro studies on the mechanism of action of hepsulfam in chronic myelogenous leukemia patients. Hincks, J.R., Adlakha, A., Cook, C.A., Johnson, C.S., Furmanski, P., Gibson, N.W. Cancer Res. (1990)
- Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias. Jaiswal, S., Traver, D., Miyamoto, T., Akashi, K., Lagasse, E., Weissman, I.L. Proc. Natl. Acad. Sci. U.S.A. (2003)
- Transforming genes in chronic myelogenous leukemia. Liu, E., Hjelle, B., Bishop, J.M. Proc. Natl. Acad. Sci. U.S.A. (1988)
- A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9. Dash, A.B., Williams, I.R., Kutok, J.L., Tomasson, M.H., Anastasiadou, E., Lindahl, K., Li, S., Van Etten, R.A., Borrow, J., Housman, D., Druker, B., Gilliland, D.G. Proc. Natl. Acad. Sci. U.S.A. (2002)
- Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis. Foti, A., Ahuja, H.G., Allen, S.L., Koduru, P., Schuster, M.W., Schulman, P., Bar-Eli, M., Cline, M.J. Blood (1991)
- Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of rat-1 fibroblasts and promotes differentiation of K562 cells. LaMontagne, K.R., Hannon, G., Tonks, N.K. Proc. Natl. Acad. Sci. U.S.A. (1998)
- Absence of alternative splicing in bcr-abl mRNA in chronic myeloid leukemia cell lines. Hermans, A., Selleri, L., Gow, J., Grosveld, G.C. Blood (1988)
- Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide. Bosch, G.J., Joosten, A.M., Kessler, J.H., Melief, C.J., Leeksma, O.C. Blood (1996)
- Propagation of human blastic myeloid leukemias in the SCID mouse. Sawyers, C.L., Gishizky, M.L., Quan, S., Golde, D.W., Witte, O.N. Blood (1992)
- Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias. Carow, C.E., Levenstein, M., Kaufmann, S.H., Chen, J., Amin, S., Rockwell, P., Witte, L., Borowitz, M.J., Civin, C.I., Small, D. Blood (1996)
- Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells. Sakai, I., Takeuchi, K., Yamauchi, H., Narumi, H., Fujita, S. Blood (2002)
- Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells. Deutsch, E., Jarrousse, S., Buet, D., Dugray, A., Bonnet, M.L., Vozenin-Brotons, M.C., Guilhot, F., Turhan, A.G., Feunteun, J., Bourhis, J. Blood (2003)
- The preferential expression of CD7 and CD34 in myeloid blast crisis in chronic myeloid leukemia. Kosugi, N., Tojo, A., Shinzaki, H., Nagamura-Inoue, T., Asano, S. Blood (2000)
- Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13. Koduru, P.R., Goh, J.C., Pergolizzi, R.G., Lichtman, S.M., Broome, J.D. Oncogene (1993)
- Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase. Johnson, J.R., Bross, P., Cohen, M., Rothmann, M., Chen, G., Zajicek, A., Gobburu, J., Rahman, A., Staten, A., Pazdur, R. Clin. Cancer Res. (2003)
- High expression of the sister-chromatid separation regulator and proto-oncogene hSecurin occurs in a subset of myeloid leukaemias but is not implicated in the pathogenesis of aneuploidy. Auner, H.W., Zebisch, A., Schimek, M.G., Bodner, C., Hiden, K., Linkesch, W., Haas, O.A., Beham-Schmid, C., Sill, H. Leukemia (2004)
- Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML. Guerrasio, A., Martinelli, G., Ambrosetti, A., Falda, M., Paolino, F., Rege-Cambrin, G., Rosso, C., Pignatti, P.F., Gasparini, P., Perona, G. Haematologica (1991)
- Autologous marrow transplantation for patients with chronic myeloid leukemia in accelerated or blastic phase: report of 14 cases. Lemonnier, M.P., Gorin, N.C., Laporte, J.P., Douay, L., Lopez, M., van den Akker, J., Stachowiak, J., David, R., Pene, F., Kantor, G. Exp. Hematol. (1986)